From: Repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine
Pre-TMS, no. = 40 | Post-TMS, no. = 40 | Test value | P value | ||
---|---|---|---|---|---|
No. of headache attacks (days per month) | Median (IQR) | 17.00 (16–22.5) | 5.00 (2–8) | − 5.515ǂ | < 0.001 |
Range | 7–27 | 0–25 | |||
Duration of individual attack (hours) | Median (IQR) | 15.63 (12.5–19.5) | 0.25 (0.13–0.53) | − 5.484ǂ | < 0.001 |
Range | 4.75–42 | 0–19.50 | |||
No. of pills (per month) | Median (IQR) | 23.00 (15–33) | 0.00 (0–1) | − 5.345ǂ | < 0.001 |
Range | 0–79 | 0–33 | |||
Pain intensity | Median (IQR) | 7.50 (7.25–7.75) | 1.63 (0.5–2.25) | − 5.450ǂ | < 0.001 |
Range | 5.25–8.75 | 0–7.75 | |||
MIDAS score | Median (IQR) | 31.00 (22.5–44) | 2.00 (0–4.5) | − 5.492ǂ | < 0.001 |
Range | 6–57 | 0–50 | |||
MIDAS grade | I | 0 (0.0%) | 33 (82.5%) | 62.280* | < 0.001 |
II | 3 (7.5%) | 4 (10.0%) | |||
III | 5 (12.5%) | 1 (2.5%) | |||
IV | 32 (80.0%) | 2 (5.0%) |